breastfeeding on semaglutide Is use during safe? Weight loss injections and breastfeeding.

Bermans program is designed around this very principle

The 9mg arm produced 26.4% mean loss

Where payers and employers are looking From the payer perspective, GLP-1s are both promising and risky

Heavy or Dependent Drinking If alcohol consumption exceeds 14+ drinks per week, or if stopping creates withdrawal symptoms: Medical supervision is essential: Combining retatrutide with heavy alcohol use requires close monitoring Address alcohol use first: Consider addiction medicine consultation before optimizing weight loss medication GLP-1 agonists may reduce alcohol cravings: Emerging research suggests these medications decrease alcohol seeking behavior in some people Liver damage risk is significant: The combination creates substantial hepatotoxic potential Consider treatment programs: Resources like CAMH (Centre for Addiction and Mental Health) offer evidence-based approaches Interestingly, some research suggests GLP-1 receptor agonists may actually help reduce alcohol consumption in people with alcohol use disorder, though this remains an area of active investigation rather than established clinical practice

None of the items offered are classified as medicinal products by the MHRA